Why Antibodies May Not Safeguard You Against COVID-19 Reinfe
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
It has been noted that if SARS-CoV-2 follows the footsteps of other pre-existing coronaviruses, reinfection will be common and will not remain to be a one-off case study. Much research is required to understand how long the antibodies developed after a recent COVID19 infection will protect a person and if the antibodies are even strong enough to fight reinfection, said Dr Anita Mathew, Infectious Disease Specialist at Fortis Hospital, Mulund.

The Indian Council of Medical Research (ICMR) is studying the reinfection episodes among those who have been treated. While more data-driven facts are awaited, it needs to be understood we cannot take antibodies for granted; they do not make for an immunity passport as the World Health Organization (WHO) aptly put it, the doctor explains.

She says while it has been established there is no fact-based understanding about the ability of our antibodies in fighting reinfection, it is important to discuss the next phase of beating the virus vaccination. There’s a need to take a closer look at how the vaccine deployment programme will progress, how soon each of us will get the jab, and why it is important to get vaccinated.

Ministry of Health and Family Welfare (MoHFW), India, recently released detailed guidelines about mass vaccination that will commence once a regulatory board approved vaccine gets the authorization.While this vaccine may be made available for emergency use, the phase 1 rollout is aimed at healthcare workers, frontline workers, people over 50 years, and those under 50 years with comorbidities.

1 share